Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$USMJ scooped a few milli at .0001 somehow yesterday morning. IMO this is going to be an interesting ride. Orders at .0001 dried up late yesterday and I'm guessing .0002 will dry up today or tomorrow. Not sure where this is riding to, but at that price, I'm in. The ridiculous share structure here is the most worrying thing to me.
No problem. Pretty clear who's legit on this site. I'll post my thoughts on stocks I follow here. I look at every aspect of the the trade from technical charting to psychology.
Thank you. Glad to connect with some REAL people here.
By the way, if anyone has the power to grant a trial message board subscription mine ran out and I've got the bank riding on some trades. Might be a week or two before funds circulate back in.
$TAUG careful with this one. Do your research and be confident with a trade here. The company is going through a lawsuit and both sides of the trade are waving heavy hands in the board. I rode this bitch from about .0033 to .008 and got out as things looked WAY overheated. It's been a couple weeks and the stocks sentiment is calling for a STRONG penny push soon IMO. I did some charting a couple weeks ago that called 06/06/16 as a turning point which scared the shit out of me so I dumped and waited to watch.
$ADMD is about to slap on the boosters and ride the rocket to the moon. Quarterly is late and several investor meetings the last on the 7th I believe. Expect HUGE gains once PR's start falling.
Who cares. The stocks sentiment is going to send it flying. People want this. Hop on and ride it imo.
Like I said weeks back, 06/06/16 looks to be a turning point. Much more positive outlook right now in my opinion... Could get interesting soon.
HotStocked is known for shorting companies into oblivion. "$USMJ Fights Back!" should be the headliner here.
IMO there's sketchier things going on against the company. Just an attempt to fight back.
Sounds like you tryin to catch some cheap shares.
Agreed. The .072 show this morning will be support in another day or two though. We're still waiting on a late quarterly filing. Only thing holding this sucker back.
I believe there's still a Quarterly to be filed... So until then, we're lucky this thing moves at all!
Interesting... a billion is nothing to big pharma anyway. a drop in the bucket. this is quite possible.
This trading range had gotten so tight it's like an atom bomb waiting to go off. Can't wait to see where we're at a week from the Quarterly release. Just gonna sit here zone out till then. I'm guessing CEO just threw us a bone before the Holiday... Wishing this would move but that's all it is right now. Wishing.
Sorry guys this is my fault. Every time I take my money out of a stock it makes the run I was trying to catch. Haven't sold yet...
Anything out of that filing you found interesting? I found a nice note about an additional fat 2mil$ deficit in some small ass lettering.
I'm smelling a penny push coming. It's delightful.
Yea, RSI looked good before today. Now it's clearly poised for another large upswing. Good luck everyone. Next week is game time.
WOWWWWWWWWWWW and that's why I don't think utilizing stop losses is a good idea in these penny stocks. A bunch of yall just got screwed. That really sucks.
Low Volume Pullback with support. Business as usual. We're just waiting on financials right now before the BLAST OFF continues.
http://www.investopedia.com/terms/l/low_volume_pullback.asp
I'm stoked.
Okay, I'm just not sure why you mentioned dogs. Are they testing dogs currently? All I heard was cats, but who knows. I haven't read up on everything...
It was my understanding they were opening the door to specific cats who had already been properly diagnosed by a previous doctor. So it may take some time for people with sick cats to find their study and register. Are they doing studies on other animals? All i read was cats with a specific set of medical conditions would be treated.
It it is concerning. Why would insiders be adding shares at the current level if there were any REAL issues? Them being late is an issue but I highly doubt they'd keep buying more at .005 to have the price drop.
That's what it looks like. Should see some movement soon one would think...
If there was an issue with the financials do you think Insiders would be scooping up as many shares as they could get? Doubtful... they aren't stupid.
TORONTO, ON--(Marketwired - May 10, 2016) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH), together with their commercial alliance partner BMV Medica SA de CV announces it has initiated partnership negotiations for Mexico and Latin American Sales & Marketing of its suite of women's health products with a multi-national Europe-based Pharma company, currently operating in over 38 countries world-wide.
Easton and its partner BMV Medica S.A de C.V have been in formal discussions over the last several months with a Europe-based Multi-National Pharma company who currently has a successful foothold within 38 countries, including Mexico, with specialized Women's Health products. The negotiations have progressed well with interest being high, which has now resulted with both companies moving toward signing a final agreement whereby this company would use its large marketing and distribution resources to take over and spearhead all marketing and distribution of Easton/BMV's VS-Sense, AmnioSense and Gynofit products beginning with Mexico. A final agreement would most likely be executed with the products being launched in stages starting with Gynofit as its first product launch. The regulatory approvals for the VS-Sense and AL-Sense products from the Mexican Ministry of Health is imminent with Gynofit already approved for sale. Although Easton is not at liberty at this time to disclose terms or names, the European multi-national company currently has sales in the Billions of Dollars throughout 38 countries. A partnership with such a company would provide Easton Pharmaceuticals with a significant increase in projected sales than if Easton was to proceed alone. Current projections from the European based company have sales for Gynofit alone at $7,000,000 within 12 months of product launch.
Easton/BMV were notified through Ackerman Pharma, the filing of its patented, point-of-care, VS-Sense Diagnostic test through "fast-track" third-party authorized reviewer Defi Latina Healthcare, S.A. de C.V. for regulatory approval in Mexico. Since submission, Defi Latina -- one of only few authorized third-party reviewers licensed by the Ministry of Health in Mexico to review and pre-approve Regulatory dossiers prior to submission -- has and continues to undergo a detailed review of the regulatory dossier for VS-Sense, a unique point-of-care vaginal discharge diagnostic test called VagiSan in Mexico. VagiSan is the brand Easton/BMV plan to launch in Mexico and Latin America, and is the same product Bayer Pharmaceuticals had licensed and launched recently in Europe under its brand Canestest, and Prestige Distribution in the US has launched under its brand Monistat, with multi-million dollars in sales.
In Mexico, the "fast-track" review process through authorized third-party reviewers can speed up approval times from several years to a few short months if the regulatory dossier is complete. Easton/BMV have worked diligently over recent months with the manufacturer CommonSense LTD of Israel, to ensure a complete dossier is in place, and expect an approval to be granted before the planned launch date of third quarter, 2016.
Prior to the VS Sense Diagnostic test regulatory filing submission, Easton/BMV Medica announced a first-order of the CommonSense products with the total number of units ordered at 230,000 -- 90,000 of the VS-Sense and 140,000 of the AmnioSense -- enough product for launch and three-six months of sales. The AmnioSense diagnostic test as well as the Gynofit bacterial vaginosis treatment are already approved in Mexico through third-party consultants, and these Marketing Authorizations (MAs) are being transferred to Easton/BMV so all three products can be launched at the same time. The European multi-national pharma company anticipates placing an initial order for Gynofit once the final agreement has been executed.
Easton/BMV anticipate the bulk of its sales initially from the Obstetrician/Gynecologist community in Mexico and have already received their first orders following the presentation of these new products this past November at the OB/GYN conference in Acapulco, attended by approximately 4,000 of the 7,000 gynecologists in Mexico.
The Amnio-Sense diagnostic product currently approved for sale in Mexico is owned exclusively for Mexican sales by Easton's partner BMV Medica, but Easton owns together with BMV the rest of Latin America sales, and Easton is in high level discussions with BMV to include AmnioSense for Mexico in the agreement currently in place.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries such as medical marijuana. The Company previously developed and owned an FDA approved wound-healing drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and owns 50% of the exclusive distribution in Mexico and Latin America for patented women's diagnostic products and two generic cancer products. Easton has made additional investments into AMFIL Technologies, a company who own rights to a product called the groZONE anti-microbial airflow system for the medical marijuana and other industries. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
http://ecigmarkets.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact:
Evan Karras
Carla Pepe
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
I think financials are gonna say 'Business as usual' Nothing of massive significance, just a neutral report which will probably raise the price as there's a lot of investors seriously worried right now. Any financials will restore investor confidence, given something crazy doesn't show up.
January huh? Which way you think this is moving till then? Glad I got out last week...
As Fetty Wap would say... 'We Boomin'
Oh I'm quite aware of how much this can possibly run. How long did FDA process take last time?
Hey, I'm just saying... Good consolidation here. Strong support...
Okay, well every indicator I look at says this thing is a go.
Good lord... I'll be up quite a bit at 4 cents. I'm just hoping for a good penny push ????
Agreed. I'm sure someone here has seen it. If it wasn't for the partnerships to get the next one through I would be much more skeptical. Perhaps I should be anyway.
Locked and loaded this chart looks ready for a PR to bust it past a penny.
Looks like a pop? Uh oh.
Down goes Frasier!